首页 | 本学科首页   官方微博 | 高级检索  
     


The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes
Authors:Drago Antonio  Crisafulli Concetta  Sidoti Antonina  Serretti Alessandro
Affiliation:Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123 Bologna, Italy.
Abstract:The glutamatergic pathway has been consistently involved in the physiopathology of depressive disorder. However a complete dissection and integration of its role in the context of other known mechanisms is lacking. We summarized and integrated the evidence of various levels of interaction between glutamatergic and monoaminergic pathways (see videos). We identified six molecular pathways, some of which with specific regional distribution within the brain. From the six pathways we identified the key proteins and their coding genes, we then provided a detailed list of possible candidates with practical suggestions for association studies planning.
Keywords:5-HT, serotonin   5-HT1A, 5-HT receptor 1A   5-HT1B, 5-HT receptor 1B   5-HT2A, 5-HT receptor 2A   5-HT6, 5-HT receptor 6   ABP, AMPAR-binding protein   AIF, apoptosis-inducing factor   AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazole propionate   Arc, cytoskeletal-associated protein   CaM, calmodulin   CaMKII, Ca2+/calmodulin-dependent protein kinases or CaM kinases   CREB, cAMP response element binding protein   DA D1, dopamine receptor D1   DA D2, dopamine receptor D2   DA D4, dopamine receptor D4   DA, dopamine   DAG, diacylglycerol   DISC1, disrupted-in-schizophrenia 1   EAAT, excitatory amino acid transporters   ERK, extracellular signal regulated kinases   GABA, gamma-aminobutyric acid   GPCRs, G protein-coupled receptors   GRIP, glutamate receptor interacting protein   GWAS, genome wide analyses studies   IDO, indoleamine 2,3-dioxygenase   iGluRs, ionotropic glutamate receptors   KA, kainate   LTDP, long term depotentiation   LTP, long term potentiation   MAP kinase, mitogene activated protein kinase   MDD, major depressive disorder   mGluRs, metabotropic glutamate receptors   NE, norepinephrine   NFL, neurofilaments   NMDA, N-methyl-d-aspartate   nNOS, nitric oxide synthase   NSF, N-ethylmaleimide-sensitive fusion protein   PAG, phosphate activated glutaminase   PARS, poly(ADP-ribose) synthase   PDE, phosphodiesterase   PI, polyphosphoinositide   PICK1, protein interacting with C alpha kinase 1   PKA, protein kinase A   PKC, protein kinase C   PLC, phospholipase C   PLC, phospholipase C   PP1, protein phosphatase 1   PSD-95, postsynaptic density 95   SAP97, synapse-associated protein 97   SERT, serotonin transporter   sGC, soluble guanylate cyclase   SNARE, soluble N-ethylmaleimide-sensitive factor attachment receptor   SYN, synaptophysin   TCA, tricarboxylic acid cycle   VGLUT, vesicular glutamate transporters   CNS, central nervous system
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号